Company intelligence / Profile preview

MGK

Minneapolis, Minnesota, United Statesmgk.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

MGK (McLaughlin Gormley King Company) is a leading life science company specializing in the development and distribution of insect control solutions for public health, animal health, and crop protection. Founded in 1902 and headquartered in Minneapolis, the company is a pioneer in botanical insecticides, particularly those derived from pyrethrum. MGK's portfolio includes a wide range of synthetic and natural products designed to manage pests that threaten human health and food security. Now a subsidiary of Sumitomo Chemical, MGK continues to innovate in the field of entomology and chemical formulation to provide sustainable and effective pest management tools globally.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeBotanical extract
Industry: Agriculture & AgTech

Partnerships

Sumitomo ChemicalValent BioSciences

Beyond the preview

Go deeper on MGK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MGK.